Two novel cases expanding the phenotype of SETD2‐related overgrowth syndrome. Issue 5 (21st April 2018)

• Record Type: Journal Article
• Authors: van Rij, Maartje C.; Hollink, Iris H. I. M.; Terhal, Paulien Anna; Kant, Sarina G.; Ruivenkamp, Claudia; van Haeringen, Arie; Kievit, J. Anneke; van Belzen, Martine J.
• Is Part Of: American journal of medical genetics. Volume 176:Issue 5(2018)
• Page Start: 1212
• Page End: 1215
• Publication Date: 2018-04-21
• Subjects: autism -- Luscan‐Lumish syndrome -- obesity -- OMIM 616831 -- overgrowth -- SETD2 -- Sotos‐like syndrome; Medical genetics -- Periodicals; 616.14205
• DOI: 10.1002/ajmg.a.38666
• Languages: English
• ISSNs: 1552-4825

Abstract

Abstract : The SETD2 ‐related overgrowth syndrome is also called "Luscan‐Lumish syndrome" (OMIM 616831) with the clinical characteristics of intellectual disability, speech delay, macrocephaly, facial dysmorphism, and autism spectrum disorders. We report on two novel patients a 4.5‐year‐old boy and a 23‐year‐old female adolescent with a speech and language developmental delay, autism spectrum disorder and macrocephaly, who were both diagnosed with SETD2‐ related overgrowth syndrome due to de novo frameshift mutations in the SETD2 gene. Features not previously described which were present in either one of our patients were nasal polyps, a large tongue with creases, a high pain threshold, constipation, and undescended testicles. These features may be related to the syndrome and may need special attention in future patients. Additionally, prevention of obesity should be an important point of attention for patients diagnosed with a SETD2 ‐related overgrowth syndrome.